139 related articles for article (PubMed ID: 24696529)
1. Breast carcinoma progression and tumour vascular markers related to apoptotic mechanisms.
Bilecova-Rabajdova M; Urban P; Gregova K; Varga J; Fialkovicová V; Kruzliak P; Marekova M
Dis Markers; 2014; 2014():156034. PubMed ID: 24696529
[TBL] [Abstract][Full Text] [Related]
2. Vascular marker expression during the development of various types of gynaecological malignancy.
Urban P; Rabajdova MB; Varga J; Kruzliak P; Fialkovicova V; Durovcova E; Marekova M
Tumour Biol; 2014 Nov; 35(11):11229-35. PubMed ID: 25113253
[TBL] [Abstract][Full Text] [Related]
3. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
4. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
Lee AH; Dublin EA; Bobrow LG; Poulsom R
J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
[TBL] [Abstract][Full Text] [Related]
5. Expression and Circulating Levels of Perlecan in Breast Cancer - Implications for Oestrogen Dependent Stromal Remodeling.
Jansson M; Billing O; Herdenberg C; Lundin C; Tolockiene E; Nazemroaya A; Sund M
J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):69-77. PubMed ID: 32124140
[TBL] [Abstract][Full Text] [Related]
6. [Development of an Innovative Cell Isolation Method for the Investigation of Breast Cancer Pathogenesis and Angiogenesis for Experimental In Vitro And In Vivo Assays].
Weigand A; Tasbihi K; Strissel PL; Strick R; Horch RE; Boos AM
Handchir Mikrochir Plast Chir; 2017 Apr; 49(2):111-122. PubMed ID: 28380641
[No Abstract] [Full Text] [Related]
7. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
Wolf B; Goebel G; Hackl H; Fiegl H
BMC Cancer; 2016 Oct; 16(1):821. PubMed ID: 27770790
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?
Attallah AM; El-Far M; Omran MM; Abdallah SO; El-Desouky MA; El-Dosoky I; Abdelrazek MA; Attallah AA; Elweresh MA; Abdel Hameed GE; Shawki HA; Salama KS; El-Waseef AM
Tumour Biol; 2014 Nov; 35(11):10737-45. PubMed ID: 25073515
[TBL] [Abstract][Full Text] [Related]
9. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.
Keyhani E; Muhammadnejad A; Behjati F; Sirati F; Khodadadi F; Karimlou M; Moghaddam FA; Pazhoomand R
Asian Pac J Cancer Prev; 2013; 14(12):7651-6. PubMed ID: 24460348
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
[No Abstract] [Full Text] [Related]
12. Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients.
Chod J; Zavadova E; Halaska MJ; Strnad P; Fucikova T; Rob L
Eur J Gynaecol Oncol; 2008; 29(6):613-6. PubMed ID: 19115689
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
[TBL] [Abstract][Full Text] [Related]
14. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
15. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
Silva J; García V; García JM; Peña C; Domínguez G; Díaz R; Lorenzo Y; Hurtado A; Sánchez A; Bonilla F
Breast Cancer Res; 2007; 9(4):R55. PubMed ID: 17711569
[TBL] [Abstract][Full Text] [Related]
16. LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.
Piccolo E; Tinari N; Semeraro D; Traini S; Fichera I; Cumashi A; La Sorda R; Spinella F; Bagnato A; Lattanzio R; D'Egidio M; Di Risio A; Stampolidis P; Piantelli M; Natoli C; Ullrich A; Iacobelli S
J Mol Med (Berl); 2013 Jan; 91(1):83-94. PubMed ID: 22864925
[TBL] [Abstract][Full Text] [Related]
17. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.
Schröder C; Witzel I; Müller V; Krenkel S; Wirtz RM; Jänicke F; Schumacher U; Milde-Langosch K
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1193-201. PubMed ID: 21590495
[TBL] [Abstract][Full Text] [Related]
20. The crucial role of emilin 1 gene expression during progression of tumor growth.
Rabajdova M; Urban P; Spakova I; Saksun L; Dudic R; Ostro A; Caprnda M; Kruzliak P; Adamek M; Marekova M
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2397-402. PubMed ID: 27581738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
